Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Investor Presentation (November 2024)
23 slides from Lifemd's investor presentation, November 2024
Slide 1: Investor Presentation
Investor Presentation November 2024 NASDAQ: LFMD
Slide 2: Important cautions regarding forward-looking statements
2 Important cautions regarding forward-looking statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Priva
Slide 3: Building the leading platform for comprehensive virtual healthcare
Building the leading platform for comprehensive virtual healthcare 1.1M Virtual Consults Conducted End-to-end, compliance-first platform for direct-to-consumer virtual primary care Early-mover advantage and partnership strategy create a deep 269,000 Active Patients competitive moat Affiliated 50-sta
Slide 4: Investment highlights
Investment highlights Proven ability to operate at scale within large and growing addressable markets thanks to robust infrastructure Differentiated, end-to-end technology platform and affiliated medical group supporting complex virtual primary care needs of 800-1,000 new patients per day Significan
Slide 5: Telehealth can solve many of the biggest problems facing the U.S. healthcare system
5 Telehealth can solve many of the biggest problems facing the U.S. healthcare system Need Solution 1/3 of Americans don’t have a primary care doctor, and At LifeMD, the median time from scheduling to the first Timeliness the average wait time to see a family doctor is 20.6 provider appointment is o
Slide 6: A $170 billion total addressable market in the U.S.
6 A $170 billion total addressable market in the U.S. LifeMD’s virtual care platform is addressing unmet needs in primary care and specialized healthcare. Male and Female Sexual Health Insomnia U.S. Primary Care Market Weight Management Integrative Health & Wellness $170B Diabetes Management Hormone
Slide 7: LifeMD has built an end-to-end platform for comprehensive virtual healthcare
7 LifeMD has built an end-to-end platform for comprehensive virtual healthcare Patient Acquisition Diagnostics Internal creative, online/offline media Integrations with Quest & LabCorp and buying, SEO, and CRM platform in-home collection Business Intelligence Telehealth Data & analytics platform to
Slide 8: Technology designed to provide best-in-class experience and care for all stakeholders
8 Technology designed to provide Best-in-class experience and care for all stakeholders For Patients For Providers For Partners For Industry Patients benefit from an intuitive virtual Streamlined workflow optimization with Flexible partnerships with unique Life sciences companies who partner care pl
Slide 9: Our affiliated medical group, staffed by full-time providers, is central to our success
Our affiliated medical group, staffed by full-time providers, is central to our success 99% 1.1M 200+ 4.9/5 Of consults start on Consults completed Different conditions Average physician rating time* LifeMD treats Dr. Gupta 98% 50 LifeMD Affiliated Provider “I love what I do because I get Patients s
Slide 10: Our success is driven by three core pillars
10 Our success is driven by three core pillars DTC Telemedicine Virtual Primary Care B2B Solutions Subscription-based treatment + Services include primary care, Digital front-door strategies for Rx Offerings urgent care, and chronic condition healthcare product companies management Established, whol
Slide 11: Our track record of strategic focus and growth
Our track record of strategic focus and growth November Launch affiliated nationwide JUNE pharmacy Commenced tech build for JUNE LifeMD Virtual Primary Care December 2023 (VPC) platform Executed $20M Acquired cloud –based telehealth technology collaboration agreement MAY platform with Medifast Cross
Slide 12: Clear strategy focused on scaling high-value revenue streams
12 Clear strategy focused on scaling high-value revenue streams Key Priorities Goals Virtual Primary Care Continue to scale weight management/GLP-1 offering High Value Revenue Streams With Long-Term Brand Equity Launch cardiovascular health and hormone therapy offerings Launch commercial health insu
Slide 13: Our management team has deep experience leading innovative healthcare organizations
Our management team has deep experience leading innovative healthcare organizations Justin Schreiber Marc Benathen Stefan Galluppi Jessica Friedeman Chief Executive Officer Chief Financial Officer Chief Innovation Chief Marketing Officer & Chairman Officer Eric Yecies Dennis Wijnker Nick Alvarez Ant
Slide 14: Our businesses have experienced rapid, consecutive YoY growth
$205M 14 Our businesses have experienced rapid, consecutive YoY Growth $54M $152M $205M $119M $54M 2024E Revenue Forecast $93M $36M 35% $25M $151M Forecast 2024 Growth Rate Versus 2023 $98M $83M $37M $68M $7M 1.1M+ $13M $2M $30M Patients & Customers $11M To-Date 2019A 2020A 2021A 2022A 2023A 2024E 1
Slide 15: Rapid and sustainable profitability growth in our core telehealth business
Rapid and sustainable profitability growth in our core telehealth business Annual telehealth adjusted EBITDA ($ millions) $6.5M $(4.5)M 2024E $(19.5)M 2023A ($35.8)M 2022A 2021A Note: adjusted EBITDA includes Telehealth only results. 2024 Forecast is based on the midpoint of the 2024 guidance range
Slide 16: Rapidly expanding telehealth gross margins and ad spend leverage
Rapidly expanding telehealth gross margins and ad spend leverage driven by patient retention are driving telehealth profitability growth Telehealth Gross Margin % Telehealth Ad Spend % of Revenue 90% 90% 80% 80% 70% 70% 60% 60% 50% 50% 40% 40% 30% 30% 20% 20% 10% 10% 0% 0% 2021 2022 2023 2024 YTD 20
Slide 17: WorkSimpli is a highly profitable asset with a strong cash flow profile
WorkSimpli is a highly profitable asset with a strong cash flow profile Global provider of Workplace and document Software-as-a-Service offerings to consumers and small businesses specializing in the pdf, resume/ HR, digital signature and forms markets Over 160,000 subscribers with platform availabl
Slide 18: 2024 guidance reflects substantial increases in both revenue and profitability
18 2024 guidance reflects substantial increases in both revenue and profitability FY 2024 GUIDANCE FY 2023 ACTUAL DELTA Telehealth Revenue $151 million $98 million +54% WorkSimpli Revenue $54 million $54 million Flat Consolidated Revenue $205 million $152 million +35% Consolidated Adj. EBITDA $14 mi
Slide 19: In summary
19 In summary Significant presence within established and growing addressable markets Proprietary technology platform differentiated by leading 50-state, affiliated physician network High margin products/services generating 85%+ consolidated gross margins Powerful telehealth infrastructure enabling
Slide 20: Appendix
Appendix LifemD*
Slide 21: Reconciliation of GAAP Net Loss to Adjusted EBITDA
Reconciliation of GAAP Net Loss to Adjusted EBITDA (in whole numbers, unaudited) (a) For the three and nine months ended September 30, 2024, the Company included litigation costs related to a class action c omplaint alleging, inter alia, unauthorized disclosure of certain information of class member
Slide 22: Reconciliation of Telehealth GAAP Net Loss to Telehealth Adjusted EBITDA
Reconciliation of Telehealth GAAP Net Loss to Telehealth Adjusted EBITDA (in whole numbers, unaudited) (a) For the three and nine months ended September 30, 2024, the Company included litigation costs related to a class action c omplaint alleging, inter alia, unauthorized disclosure of certain infor
Slide 23: Company Contact
Company Contact Marc Benathen marc@lifemd.com Media Contact press@lifemd.com